Becky Bosley

The work doesn’t stop here. Myeloma Action Month may be ending, but our commitment continues every single day. Let’s keep going and show the world that we are #MoreThanMyeloma .

To the patients showing unwavering strength, the care partners giving so much of themselves, the clinicians and researchers advancing care, and the advocates working tirelessly behind the scenes, this progress belongs to all of you.

Day 31: Wow, what an impact! As #MyelomaActionMonth comes to a close, I’m reflecting on the incredible momentum we’ve built together.

There is a severe lack of availability across the world to all classes of myeloma treatments and these treatments improve outcomes. Advocacy in so many ways is so imperative! #MyelomaActionMonth #MoreThanMyeloma

In addition, financial & insurance barriers exist, as these therapies are not inexpensive. These are only the barriers here in the US, nevermind the rest of the globe.

Day 28: Immunotherapy in myeloma There are many different classes of drugs approved in the treatment of myeloma, but those that engage the patient's own immune system have been the gamechangers when it comes to deep, durable remissions.

Hill yeah, we advocate! #morethanmyeloma #myeloma #advocacy #patient #myelomaactionmonth

*prior authorizations, with the Improving Seniors Timely Access To Care Act *promote clinical trials with the Clinical Trials Modernization Act *oral parity through the Cancer Drug Parity Act These will not only help the myeloma coMMunity, but the entire patient population.

Day 27: Measurable Action! Yesterday, the @IMFmyeloma #advocacy team brought 24 advocates to Capitol Hill to engage in 47 meetings with members of congress. Copying @RiottoMa words on patient voice in advocacy. What powerful action during this #MyelomaActionMonth !